The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Review the importance of biomarker testing in oncology patients, primarily in the solid tumor setting
Describe racial, LGBTQ+,Aand socioeconomic inequities that impact biomarker testing rates
Discuss ways that oncology advanced practitioners can minimize the impact of racial, LBGTQ+, and socioeconomic inequities on biomarker testing in their own practices